Transmissible spongiform encephalopathies

被引:175
作者
Collins, SJ [1 ]
Lawson, VA
Masters, CL
机构
[1] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia
[2] Australian Natl Creutzfeldt Jakob Dis Registry, Melbourne, Vic, Australia
[3] Mental Hlth Res Inst Victoria, Melbourne, Vic, Australia
关键词
D O I
10.1016/S0140-6736(03)15171-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nosologically, transmissible spongiform encephalopathies (TSE or prion diseases) should be grouped with other neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, which are all caused by toxic gain of function of an aberrant form of a constitutively expressed protein. Failure to clear these proteins from the brain induces neuronal dysfunction. Transmissibility is the property that separates TSE from other neurodegenerative diseases, and this property seems to reside within the structure of the abnormal protein. The human phenotypic range of these encephalopathies includes Creutzfeldt-Jakob disease and its variant form, kuru, Gerstmann-Straussler-Scheinker syndrome, and fatal familial insomnia. Notwithstanding the generally low incidence of TSE and their limited infectiousness, major epidemics such as bovine spongiform encephalopathy and kuru arise in situations where intraspecies recycling of the abnormal protein is sustained. Moreover, evidence of chronic subclinical infection in animals offers insights into pathogenesis and prompts re-evaluation of the notion of species barriers and present infection control measures. Since case-to-case transmission is the only known mechanism underlying epidemics of TSE, potential reservoirs of infectivity in the tails of epidemics need continued vigilance.
引用
收藏
页码:51 / 61
页数:11
相关论文
共 129 条
[41]   NMR structure of the bovine prion protein [J].
Garcia, FL ;
Zahn, R ;
Riek, R ;
Wüthrich, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (15) :8334-8339
[42]   Copper binding to the octarepeats of the prion protein - Affinity, specificity, folding, and cooperativity: Insights from circular dichroism [J].
Garnett, AP ;
Viles, JH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (09) :6795-6802
[43]   Incidence of Creutzfeldt-Jakob disease in Switzerland [J].
Glatzel, M ;
Rogivue, C ;
Ghani, A ;
Streffer, JR ;
Amsler, L ;
Aguzzi, A .
LANCET, 2002, 360 (9327) :139-141
[44]   Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease [J].
Glatzel, M ;
Abela, E ;
Maissen, M ;
Aguzzi, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (19) :1812-1820
[45]   CREUTZFELDT-JAKOB DISEASE ASSOCIATED WITH THE PRNP CODON-200LYS MUTATION - AN ANALYSIS OF 45 FAMILIES [J].
GOLDFARB, LG ;
BROWN, P ;
MITROVA, E ;
CERVENAKOVA, L ;
GOLDIN, L ;
KORCZYN, AD ;
CHAPMAN, J ;
GALVEZ, S ;
CARTIER, L ;
RUBENSTEIN, R ;
GAJDUSEK, DC .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1991, 7 (05) :477-486
[46]   FATAL FAMILIAL INSOMNIA AND FAMILIAL CREUTZFELDT-JAKOB DISEASE - DISEASE PHENOTYPE DETERMINED BY A DNA POLYMORPHISM [J].
GOLDFARB, LG ;
PETERSEN, RB ;
TABATON, M ;
BROWN, P ;
LEBLANC, AC ;
MONTAGNA, P ;
CORTELLI, P ;
JULIEN, J ;
VITAL, C ;
PENDELBURY, WW ;
HALTIA, M ;
WILLS, PR ;
HAUW, JJ ;
MCKEEVER, PE ;
MONARI, L ;
SCHRANK, B ;
SWERGOLD, GD ;
AUTILIOGAMBETTI, L ;
GAJDUSEK, DC ;
LUGARESI, E ;
GAMBETTI, P .
SCIENCE, 1992, 258 (5083) :806-808
[47]   Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease [J].
Green, AJE ;
Thompson, EJ ;
Stewart, GE ;
Zeidler, M ;
McKenzie, JM ;
MacLeod, MA ;
Ironside, JW ;
Will, RG ;
Knight, RSG .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2001, 70 (06) :744-748
[48]  
Guinan E, 1998, B I PASTEUR, V96, P207
[49]  
HADLOW WJ, 1959, LANCET, V2, P289
[50]   A transmembrane form of the prion protein in neurodegenerative disease [J].
Hegde, RS ;
Mastrianni, JA ;
Scott, MR ;
DeFea, KA ;
Tremblay, P ;
Torchia, M ;
DeArmond, SJ ;
Prusiner, SB ;
Lingappa, VR .
SCIENCE, 1998, 279 (5352) :827-834